BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 23230789)

  • 1. Model mammals. Sheep are helping scientists gain ground against Huntington's disease.
    Yuhas D
    Sci Am; 2012 Dec; 307(6):17. PubMed ID: 23230789
    [No Abstract]   [Full Text] [Related]  

  • 2. Animal models of Huntington's disease.
    Gárdián G
    Ideggyogy Sz; 2006 Nov; 59(11-12):396-9. PubMed ID: 17203874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fly models of Huntington's disease.
    Marsh JL; Pallos J; Thompson LM
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R187-93. PubMed ID: 12925571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt is altered in an animal model of Huntington's disease and in patients.
    Colin E; Régulier E; Perrin V; Dürr A; Brice A; Aebischer P; Déglon N; Humbert S; Saudou F
    Eur J Neurosci; 2005 Mar; 21(6):1478-88. PubMed ID: 15845076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.
    Antal A; Bodis-Wollner I
    Neurobiology (Bp); 1993; 1(2):101-22. PubMed ID: 8111350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline is protective in a mouse model of Huntington's disease.
    Hersch S; Fink K; Vonsattel JP; Friedlander RM
    Ann Neurol; 2003 Dec; 54(6):841; author reply 842-3. PubMed ID: 14681897
    [No Abstract]   [Full Text] [Related]  

  • 7. Animal welfare and the refinement of neuroscience research methods--a case study of Huntington's disease models.
    Olsson IA; Hansen AK; Sandøe P
    Lab Anim; 2008 Jul; 42(3):277-83. PubMed ID: 18625582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease.
    Diguet E; Rouland R; Tison F
    Ann Neurol; 2003 Dec; 54(6):841-2. PubMed ID: 14681898
    [No Abstract]   [Full Text] [Related]  

  • 9. Kainic acid animal model predicts therapeutic agents in Huntington's chorea.
    Borison RL; Diamond BI
    Trans Am Neurol Assoc; 1979; 104():67-9. PubMed ID: 162258
    [No Abstract]   [Full Text] [Related]  

  • 10. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Model of choreic movement in monkey--contribution for understanding the mechanism of chorea in Huntington's disease].
    Kanazawa I
    Jikken Dobutsu; 1990 Apr; 39(2):168-72. PubMed ID: 2141819
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citicoline is not protective in experimental models of Huntington's disease.
    Mievis S; Levivier M; Vassart G; Brotchi J; Ledent C; Blum D
    Neurobiol Aging; 2007 Dec; 28(12):1944-6. PubMed ID: 17064815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease.
    Rafael H
    Neurosurgery; 2002 Sep; 51(3):852-3. PubMed ID: 12229869
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental therapeutics in transgenic mouse models of Huntington's disease.
    Beal MF; Ferrante RJ
    Nat Rev Neurosci; 2004 May; 5(5):373-84. PubMed ID: 15100720
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards a therapy for Huntington's disease (Commentary on Giampà et al.).
    Hannan AJ
    Eur J Neurosci; 2009 Mar; 29(5):901. PubMed ID: 19291220
    [No Abstract]   [Full Text] [Related]  

  • 17. [Huntington's disease: clinical and molecular genetics].
    Warita H; Shiro Y; Kashihara K; Abe K
    Nihon Rinsho; 1999 Apr; 57(4):896-9. PubMed ID: 10222786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limbic neurogenesis/plasticity in the R6/2 mouse model of Huntington's disease.
    Phillips W; Morton AJ; Barker RA
    Neuroreport; 2006 Oct; 17(15):1623-7. PubMed ID: 17001281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huntington's disease: modeling the gait disorder and proposing novel treatments.
    Banaie M; Sarbaz Y; Gharibzadeh S; Towhidkhah F
    J Theor Biol; 2008 Sep; 254(2):361-7. PubMed ID: 18621402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Huntington's disease on the human and mouse proteome.
    Zabel C; Klose J
    Int Rev Neurobiol; 2004; 61():241-83. PubMed ID: 15482818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.